mhurhangee/ep-ind-claims huggingface dataset:
A display device comprising: a substrate; a first electrode and a second electrode that extend in a second direction on the substrate and are spaced apart from each other in a first direction on the substrate perpendicular to the second direction; a first passivation layer disposed on the substrate and overlapping the first electrode and the second electrode in a vertical direction which is perpendicular to the substrate; at least one light-emitting element disposed on the first passivation layer and having ends disposed on the first electrode and the second electrode, respectively; a first organic insulating layer disposed between the first passivation layer and the at least one light-emitting element; a second organic insulating layer disposed on the at least one light-emitting element; a first contact electrode disposed on the first electrode and electrically contacting a first end of the at least one light-emitting element; a second contact electrode disposed on the second electrode and electrically contacting a second end of the at least one light-emitting element; and a second passivation layer disposed on the second organic insulating layer, wherein the first contact electrode is in direct contact with an end of each of the second organic insulating layer and the second passivation layer, the second contact electrode is in direct contact with another end of each of the second organic insulating layer and the second passivation layer, and the first contact electrode and the second contact electrode are not in direct contact with an upper surface of the second passivation layer. a substrate; a first electrode and a second electrode that extend in a second direction on the substrate and are spaced apart from each other in a first direction on the substrate perpendicular to the second direction; a first passivation layer disposed on the substrate and overlapping the first electrode and the second electrode in a vertical direction which is perpendicular to the substrate; at least one light-emitting element disposed on the first passivation layer and having ends disposed on the first electrode and the second electrode, respectively; a first organic insulating layer disposed between the first passivation layer and the at least one light-emitting element; a second organic insulating layer disposed on the at least one light-emitting element; a first contact electrode disposed on the first electrode and electrically contacting a first end of the at least one light-emitting element; a second contact electrode disposed on the second electrode and electrically contacting a second end of the at least one light-emitting element; and a second passivation layer disposed on the second organic insulating layer, wherein the first contact electrode is in direct contact with an end of each of the second organic insulating layer and the second passivation layer, the second contact electrode is in direct contact with another end of each of the second organic insulating layer and the second passivation layer, and the first contact electrode and the second contact electrode are not in direct contact with an upper surface of the second passivation layer.
A one-step process for a preparation of a protected DO3A salt of formula where: X is a chlorine, iodine or bromine anion; y is an integer from 1 to 3; and R is a C 1 -C 6 alkyl or an aryl group; said process comprising: 1) reacting Cyclen with an activated acetic ester of formula XCH 2 COOR, in an organic solvent and in the presence of an auxiliary base, to give a mixture; 2) adding water to the mixture of step 1) in an amount by weight of ten times or less with respect to the amount of Cyclen, to obtain a suspension comprising protected DO3A as a solid salt of formula; and 3) collecting and washing the protected DO3A salt. X is a chlorine, iodine or bromine anion; y is an integer from 1 to 3; and R is a C 1 -C 6 alkyl or an aryl group; said process comprising: 1) reacting Cyclen with an activated acetic ester of formula XCH 2 COOR, in an organic solvent and in the presence of an auxiliary base, to give a mixture; 2) adding water to the mixture of step 1) in an amount by weight of ten times or less with respect to the amount of Cyclen, to obtain a suspension comprising protected DO3A as a solid salt of formula; and 3) collecting and washing the protected DO3A salt.
A method for preparing a soda-lime-silica glass basic formulation, comprising the steps of: a1) pre-desiliconizing silicon-containing powdery industrial waste with a sodium hydroxide solution, and separating, to obtain a pre-desiliconization mother liquor and residues; a2) introducing carbon dioxide to the pre-desiliconization mother liquor for carbonation decomposition, and separating, to obtain a silicic acid precipitate and a sodium carbonate solution; a3) drying the silicic acid precipitate to obtain silicon dioxide; a4) adding lime milk into the sodium carbonate solution for causticization, and separating, to obtain a calcium carbonate precipitate and a sodium hydroxide solution; a5) drying the calcium carbonate precipitate; and a6) according to the requirements on the amounts of respective components in the soda-lime-silica glass, using the silicon dioxide prepared in step a3) and part of the dried calcium carbonate from step a5) and adding sodium oxide thereto, to obtain a soda-lime-silica glass basic formulation. a1) pre-desiliconizing silicon-containing powdery industrial waste with a sodium hydroxide solution, and separating, to obtain a pre-desiliconization mother liquor and residues; a2) introducing carbon dioxide to the pre-desiliconization mother liquor for carbonation decomposition, and separating, to obtain a silicic acid precipitate and a sodium carbonate solution; a3) drying the silicic acid precipitate to obtain silicon dioxide; a4) adding lime milk into the sodium carbonate solution for causticization, and separating, to obtain a calcium carbonate precipitate and a sodium hydroxide solution; a5) drying the calcium carbonate precipitate; and a6) according to the requirements on the amounts of respective components in the soda-lime-silica glass, using the silicon dioxide prepared in step a3) and part of the dried calcium carbonate from step a5) and adding sodium oxide thereto, to obtain a soda-lime-silica glass basic formulation.
An organic hydrophilic coating composition, comprising: a polyvinyl alcohol resin as a resin component, wherein the polyvinyl alcohol resin comprises a completely saponified polyvinyl alcohol having a degree of saponification of 97 mol% or more and 99.8 mol% or less; as a resin component, a polyethylene glycol resin in addition to the polyvinyl alcohol resin; and a phenol compound as an additional component, wherein the phenol compound, which is contained as the additional component, is selected from phenol antioxidants, has two or more hydroxyphenyl groups in its molecule, and each of the hydroxyphenyl groups has a bulky substituent that exhibits an effect of steric hindrance on a hydroxyl group. a polyvinyl alcohol resin as a resin component, wherein the polyvinyl alcohol resin comprises a completely saponified polyvinyl alcohol having a degree of saponification of 97 mol% or more and 99.8 mol% or less; as a resin component, a polyethylene glycol resin in addition to the polyvinyl alcohol resin; and a phenol compound as an additional component, wherein the phenol compound, which is contained as the additional component, is selected from phenol antioxidants, has two or more hydroxyphenyl groups in its molecule, and each of the hydroxyphenyl groups has a bulky substituent that exhibits an effect of steric hindrance on a hydroxyl group.
A radiation image processing device which performs processing on a two-dimensional radiation image imaged without using a scattered radiation elimination grid by irradiating a subject with radiation and generating a processed two-dimensional radiation image provided for diagnosis, the radiation image processing device comprising: characteristic acquisition means for acquiring a virtual grid characteristic according to a type of a grid assumed to be used to eliminate the scattered radiation included in radiation transmitted through the subject at the time of imaging of the two-dimensional radiation image; and scattering information acquisition means for acquiring scattered radiation content distribution in the two-dimensional radiation image representing a scattered component of radiation included in the two-dimensional radiation image, scattered radiation elimination means for performing scattered radiation elimination processing of the two-dimensional radiation image based on the virtual grid characteristic and the scattered radiation content distribution and for generating a processed two-dimensional radiation image provided for diagnosis, wherein the characteristic acquisition means acquires, as the virtual grid characteristic, a transmittance to the scattered radiation and a transmittance to primary radiation included in radiation transmitted through the subject. characteristic acquisition means for acquiring a virtual grid characteristic according to a type of a grid assumed to be used to eliminate the scattered radiation included in radiation transmitted through the subject at the time of imaging of the two-dimensional radiation image; and scattering information acquisition means for acquiring scattered radiation content distribution in the two-dimensional radiation image representing a scattered component of radiation included in the two-dimensional radiation image, scattered radiation elimination means for performing scattered radiation elimination processing of the two-dimensional radiation image based on the virtual grid characteristic and the scattered radiation content distribution and for generating a processed two-dimensional radiation image provided for diagnosis, wherein the characteristic acquisition means acquires, as the virtual grid characteristic, a transmittance to the scattered radiation and a transmittance to primary radiation included in radiation transmitted through the subject.
Apparatus arranged for off-line measurement of a property or a plurality of properties of a predetermined process stream sample volume of a relatively high viscosity, inhomogeneous liquid hydrocarbon mixture including crude or heavy oils having asphaltenic or carbonaceous particulates therein, said apparatus comprising: a fluid flow path configured to convey said predetermined process stream sample volume of the liquid hydrocarbon mixture continuously in a downstream direction therethrough; a sampling unit configured to receive the process stream sample volume therein, and to continuously deliver the process stream sample volume to the fluid flow path, the sampling unit including: a temperature control module configured to maintain at least a portion of the process stream sample volume at a predetermined setpoint temperature; a homogenization module configured to distribute the particulates within the process stream sample volume; and a flow control module configured to maintain a substantially constant flow rate of the process stream sample volume as it flows through the fluid flow path; a sample cell disposed within the fluid flow path; a spectrometer communicably coupled to the sample cell, to transmit and receive radiation to and from the sample cell; the spectrometer configured to measure spectra of the process stream sample volume in the sample cell, including the crude or heavy oils having asphaltenic or carbonaceous particulates; and a processor configured to capture the spectra. a fluid flow path configured to convey said predetermined process stream sample volume of the liquid hydrocarbon mixture continuously in a downstream direction therethrough; a sampling unit configured to receive the process stream sample volume therein, and to continuously deliver the process stream sample volume to the fluid flow path, the sampling unit including: a temperature control module configured to maintain at least a portion of the process stream sample volume at a predetermined setpoint temperature; a homogenization module configured to distribute the particulates within the process stream sample volume; and a flow control module configured to maintain a substantially constant flow rate of the process stream sample volume as it flows through the fluid flow path; a temperature control module configured to maintain at least a portion of the process stream sample volume at a predetermined setpoint temperature; a homogenization module configured to distribute the particulates within the process stream sample volume; and a flow control module configured to maintain a substantially constant flow rate of the process stream sample volume as it flows through the fluid flow path; a sample cell disposed within the fluid flow path; a spectrometer communicably coupled to the sample cell, to transmit and receive radiation to and from the sample cell; the spectrometer configured to measure spectra of the process stream sample volume in the sample cell, including the crude or heavy oils having asphaltenic or carbonaceous particulates; and a processor configured to capture the spectra.
An isolated caninized antibody that specifically binds interleukin-4 receptor alpha (IL4Rα) comprising a canine IgG heavy chain and a canine kappa light chain; wherein the canine kappa light chain comprises three light chain complementary determining regions (CDRs): CDR light 1 (CDRL1), CDR light 2 (CDRL2), and CDR light 3 (CDRL3), and the canine IgG heavy chain comprises three heavy chain CDRs: CDR heavy 1 (CDRH1), CDR heavy 2 (CDRH2) and CDR heavy 3 (CDRH3): (a) wherein CDRL1 comprises the amino acid sequence of SEQ ID NO: 43; (b) wherein CDRL2 comprises the amino acid sequence comprising SEQ ID NO: 44; (c) wherein CDRL3 comprises the amino acid sequence of SEQ ID NO: 45; (d) wherein CDRH1 comprises the amino acid sequence of SEQ ID NO: 46; (e) wherein CDRH2 comprises the amino acid sequence of SEQ ID NO: 47; and (f) wherein CDRH3 comprises the amino acid sequence of SEQ ID NO: 48; wherein the IgG heavy chain comprises an amino acid sequence selected from the group consisting of SEQ ID NO: 28, SEQ ID NO: 30, and SEQ ID NO: 32. (a) wherein CDRL1 comprises the amino acid sequence of SEQ ID NO: 43; (b) wherein CDRL2 comprises the amino acid sequence comprising SEQ ID NO: 44; (c) wherein CDRL3 comprises the amino acid sequence of SEQ ID NO: 45; (d) wherein CDRH1 comprises the amino acid sequence of SEQ ID NO: 46; (e) wherein CDRH2 comprises the amino acid sequence of SEQ ID NO: 47; and (f) wherein CDRH3 comprises the amino acid sequence of SEQ ID NO: 48;
A cross-chain data trusted management method, applied to a relay, wherein a trusted execution environment, TEE, is loaded onto the relay to implement the following steps in the TEE: invoking, based on a cross-chain request from a first blockchain, corresponding cross-chain data from a second blockchain that serves as a requested object, wherein the relay is configured with a client device of the second blockchain; loading a preconfigured management rule set to manage the cross-chain data based on a management rule comprised in the management rule set to obtain processed data; and returning, to the first blockchain, a response result that comprises the processed data, an identity signature of the relay, information about the management rule set and a public key that uniquely matches the information about the management rule set to prove that the processed data is obtained by managing the cross-chain data based on the management rule set. invoking, based on a cross-chain request from a first blockchain, corresponding cross-chain data from a second blockchain that serves as a requested object, wherein the relay is configured with a client device of the second blockchain; loading a preconfigured management rule set to manage the cross-chain data based on a management rule comprised in the management rule set to obtain processed data; and returning, to the first blockchain, a response result that comprises the processed data, an identity signature of the relay, information about the management rule set and a public key that uniquely matches the information about the management rule set to prove that the processed data is obtained by managing the cross-chain data based on the management rule set.
A method for encapsulating quantum dots; said method comprising steps of: (a) mixing quantum dots with a polymer having a weight average molecular weight from 1,000 to 200,000 and a solubility parameter from 14 to 18.75 (J/cm 3) 1/2 and a C 6 -C 10 aromatic hydrocarbon solvent to form a mixture; and (b) spray drying the mixture to produce an encapsulated quantum dot powder; wherein the polymer comprises polymerized units of a compound chosen from isobornyl (meth)acrylate, C 2 -C 18 alkyl (meth)acrylates, L-menthyl acrylate, tricyclo[5.2.1.0 2,6]decylmethyl acrylate, C 1 -C 6 alkylstyrenes, and 3,3,5-trimethylcyclohexyl methacrylate. (a) mixing quantum dots with a polymer having a weight average molecular weight from 1,000 to 200,000 and a solubility parameter from 14 to 18.75 (J/cm 3) 1/2 and a C 6 -C 10 aromatic hydrocarbon solvent to form a mixture; and (b) spray drying the mixture to produce an encapsulated quantum dot powder;
A surgical suture apparatus comprising: an upper support; an opposite, lower support; a surgical needle; and a needle driving part, wherein the lower support, the surgical needle and the needle driving part form a suture part, wherein the surgical needle is configured to operate relative to the lower support by the needle driving part, such that a first suture thread from the surgical needle and a second suture thread from the lower support are entangled with each other by the operation of the surgical needle, characterized in that the upper support includes a rail, the needle driving part is configured to move along the rail located on the upper support while facing to the lower support, and the needle driving part is configured to be actuated based on a control signal inputted from an external apparatus. an upper support; an opposite, lower support; a surgical needle; and a needle driving part, wherein the lower support, the surgical needle and the needle driving part form a suture part, wherein the surgical needle is configured to operate relative to the lower support by the needle driving part, such that a first suture thread from the surgical needle and a second suture thread from the lower support are entangled with each other by the operation of the surgical needle,
Wiring system for building structure premises, in particular for use in the tertiary sector, comprising: - a main distribution frame installed in an equipment room, the main distribution frame comprising at least one optical drawer for receiving optical cassettes, - at least one optical trunk cable connected to an optical cassette of the main distribution frame and extending into an operating space, - at least one medium-voltage power cable which follows the optical trunk cable, - at least one ACP installed in the operating space and connected to the optical trunk cable, characterized in that the ACP contains at least: - at least one DIN- or 19"-format industrial switch, - at least one power supply for the industrial switch linked to the power cable, - at least one DIN box (73, 75) provided with optical connection blocks (74in, 74out) to which the optical trunk cable is connected, - at least one DIN rail (73', 75') for mounting the DIN box (73, 75), - optical cross-connection wires linking the optical connection blocks (74in, 74out) to the industrial switch, - RJ45 leads and/or extensions and/or optical jumpers originating from the box and connected to the peripherals installed in the operating space. - a main distribution frame installed in an equipment room, the main distribution frame comprising at least one optical drawer for receiving optical cassettes, - at least one optical trunk cable connected to an optical cassette of the main distribution frame and extending into an operating space, - at least one medium-voltage power cable which follows the optical trunk cable, - at least one ACP installed in the operating space and connected to the optical trunk cable, characterized in that the ACP contains at least: - at least one DIN- or 19"-format industrial switch, - at least one power supply for the industrial switch linked to the power cable, - at least one DIN box (73, 75) provided with optical connection blocks (74in, 74out) to which the optical trunk cable is connected, - at least one DIN rail (73', 75') for mounting the DIN box (73, 75), - optical cross-connection wires linking the optical connection blocks (74in, 74out) to the industrial switch, - at least one DIN- or 19"-format industrial switch, - at least one power supply for the industrial switch linked to the power cable, - at least one DIN box (73, 75) provided with optical connection blocks (74in, 74out) to which the optical trunk cable is connected, - at least one DIN rail (73', 75') for mounting the DIN box (73, 75), - optical cross-connection wires linking the optical connection blocks (74in, 74out) to the industrial switch, - RJ45 leads and/or extensions and/or optical jumpers originating from the box and connected to the peripherals installed in the operating space.
A pharmaceutical composition comprising zaltoprofen for use in the prevention of metastasis of giant cell tumor occurring in a bone and soft tissue, metastasis of chondrosarcoma, or metastasis of bone sarcoma.
A spinal rod (20, 120, 320) comprising: a first rod portion having an elongate rod section adapted for connection with a first fixation element implanted in a first vertebra, the first rod portion including an internal hollow cavity defined by an internal wall surface; a second rod portion having an elongate rod section adapted for connection with a second fixation element implanted in a second vertebra, wherein the second rod portion is inserted within the internal cavity of the first rod portion and is axially movable relative to the first rod portion within the internal cavity in an expansion direction, the rod sealingly engaging the internal wall surface and thereby defining a hydraulic pressure chamber (44, 344), wherein the hydraulic pressure chamber is fluidly sealed off from the internal hollow cavity; an injection port and a flow channel in fluid communication with the hydraulic pressure chamber; the spinal rod being characterized in that it further comprises: a locking mechanism engageable with the second rod portion, the locking mechanism being effective to lock the second rod portion relative to the first rod portion. a first rod portion having an elongate rod section adapted for connection with a first fixation element implanted in a first vertebra, the first rod portion including an internal hollow cavity defined by an internal wall surface; a second rod portion having an elongate rod section adapted for connection with a second fixation element implanted in a second vertebra, wherein the second rod portion is inserted within the internal cavity of the first rod portion and is axially movable relative to the first rod portion within the internal cavity in an expansion direction, the rod sealingly engaging the internal wall surface and thereby defining a hydraulic pressure chamber (44, 344), wherein the hydraulic pressure chamber is fluidly sealed off from the internal hollow cavity; an injection port and a flow channel in fluid communication with the hydraulic pressure chamber; the spinal rod being characterized in that it further comprises: a locking mechanism engageable with the second rod portion, the locking mechanism being effective to lock the second rod portion relative to the first rod portion. a locking mechanism engageable with the second rod portion, the locking mechanism being effective to lock the second rod portion relative to the first rod portion.